Evaluating Federal Policy Changes to Hospice Benefit, Use by Patients With Alzheimer Disease, Related Dementias

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 6, 2022

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.0900?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=050622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: This study of Medicare claims data found that there were immediate declines in the share of patients receiving hospice care with Alzheimer disease and related dementias and a slower growth in use of hospice care by these patients after implementation of Medicare policy changes that aimed to reduce long hospice stays.

Authors: Kan Z. Gianattasio, M.P.P., of the George Washington University Milken Institute School of Public Health in Washington, D.C., is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.0900)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.